Literature DB >> 21204525

NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG)₂ reveal a dynamic UU internal loop found in myotonic dystrophy type 1.

Raman Parkesh1, Matthew Fountain, Matthew D Disney.   

Abstract

The NMR structure of an RNA with a copy of the 5'CUG/3'GUC motif found in the triplet repeating disorder myotonic dystrophy type 1 (DM1) is disclosed. The lowest energy conformation of the UU pair is a single-hydrogen bond structure; however, the UU protons undergo exchange indicating structural dynamics. Molecular dynamics simulations show that the single hydrogen bond structure is the most populated one but the UU pair interconverts among zero, one, and two hydrogen bond pairs. These studies have implications for the recognition of the DM1 RNA by small molecules and proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204525      PMCID: PMC3031998          DOI: 10.1021/bi101896j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

2.  NMR spectroscopy of RNA duplexes containing pseudouridine in supercooled water.

Authors:  Kersten T Schroeder; Jack J Skalicky; Nancy L Greenbaum
Journal:  RNA       Date:  2005-07       Impact factor: 4.942

Review 3.  Targeting RNA with small molecules.

Authors:  Jason R Thomas; Paul J Hergenrother
Journal:  Chem Rev       Date:  2008-03-25       Impact factor: 60.622

Review 4.  Mismatch base pairs in RNA.

Authors:  S Limmer
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1997

5.  Terminal base pairs of oligodeoxynucleotides: imino proton exchange and fraying.

Authors:  S Nonin; J L Leroy; M Guéron
Journal:  Biochemistry       Date:  1995-08-22       Impact factor: 3.162

6.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

7.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

8.  The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.

Authors:  Blaine H M Mooers; Jeremy S Logue; J Andrew Berglund
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-03       Impact factor: 11.205

9.  Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.

Authors:  John D Lueck; Ami Mankodi; Maurice S Swanson; Charles A Thornton; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2006-12-11       Impact factor: 4.086

10.  Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).

Authors:  Peter C Gareiss; Krzysztof Sobczak; Brian R McNaughton; Prakash B Palde; Charles A Thornton; Benjamin L Miller
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

View more
  20 in total

1.  Structure and Dynamics of RNA Repeat Expansions That Cause Huntington's Disease and Myotonic Dystrophy Type 1.

Authors:  Jonathan L Chen; Damian M VanEtten; Matthew A Fountain; Ilyas Yildirim; Matthew D Disney
Journal:  Biochemistry       Date:  2017-06-29       Impact factor: 3.162

2.  Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1 × 1 nucleotide UU internal loop conformations.

Authors:  Amit Kumar; HaJeung Park; Pengfei Fang; Raman Parkesh; Min Guo; Kendall W Nettles; Matthew D Disney
Journal:  Biochemistry       Date:  2011-10-20       Impact factor: 3.162

Review 3.  Methods to enable the design of bioactive small molecules targeting RNA.

Authors:  Matthew D Disney; Ilyas Yildirim; Jessica L Childs-Disney
Journal:  Org Biomol Chem       Date:  2014-02-21       Impact factor: 3.876

4.  Utilizing the GAAA tetraloop/receptor to facilitate crystal packing and determination of the structure of a CUG RNA helix.

Authors:  Leslie A Coonrod; Jeremy R Lohman; J Andrew Berglund
Journal:  Biochemistry       Date:  2012-10-12       Impact factor: 3.162

5.  A crystal structure of a model of the repeating r(CGG) transcript found in fragile X syndrome.

Authors:  Amit Kumar; Pengfei Fang; Hajeung Park; Min Guo; Kendall W Nettles; Matthew D Disney
Journal:  Chembiochem       Date:  2011-07-15       Impact factor: 3.164

Review 6.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

7.  Investigating the binding mode of an inhibitor of the MBNL1·RNA complex in myotonic dystrophy type 1 (DM1) leads to the unexpected discovery of a DNA-selective binder.

Authors:  Chun-Ho Wong; Stacie L Richardson; Yen-Jun Ho; Alex M H Lucas; Tiziano Tuccinardi; Anne M Baranger; Steven C Zimmerman
Journal:  Chembiochem       Date:  2012-10-24       Impact factor: 3.164

8.  A dynamic structural model of expanded RNA CAG repeats: a refined X-ray structure and computational investigations using molecular dynamics and umbrella sampling simulations.

Authors:  Ilyas Yildirim; HaJeung Park; Matthew D Disney; George C Schatz
Journal:  J Am Chem Soc       Date:  2013-02-26       Impact factor: 15.419

Review 9.  Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts.

Authors:  Matthew D Disney
Journal:  Drug Discov Today       Date:  2013-08-09       Impact factor: 7.851

10.  Features of modularly assembled compounds that impart bioactivity against an RNA target.

Authors:  Suzanne G Rzuczek; Yu Gao; Zhen-Zhi Tang; Charles A Thornton; Thomas Kodadek; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.